Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)DivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

TrueBlue (TBI) Change in Receivables (2017 - 2025)

TrueBlue (TBI) has disclosed Change in Receivables for 17 consecutive years, with -$8.9 million as the latest value for Q4 2025.

  • On a quarterly basis, Change in Receivables rose 9.88% to -$8.9 million in Q4 2025 year-over-year; TTM through Dec 2025 was $15.5 million, a 143.28% increase, with the full-year FY2025 number at $15.5 million, up 143.28% from a year prior.
  • Change in Receivables was -$8.9 million for Q4 2025 at TrueBlue, down from $26.7 million in the prior quarter.
  • In the past five years, Change in Receivables ranged from a high of $37.1 million in Q3 2021 to a low of -$31.0 million in Q1 2023.
  • A 5-year average of -$1.5 million and a median of -$8.9 million in 2022 define the central range for Change in Receivables.
  • Peak YoY movement for Change in Receivables: skyrocketed 1710.47% in 2021, then plummeted 184.93% in 2023.
  • TrueBlue's Change in Receivables stood at $28.0 million in 2021, then plummeted by 147.79% to -$13.4 million in 2022, then crashed by 64.24% to -$22.0 million in 2023, then skyrocketed by 54.81% to -$9.9 million in 2024, then increased by 9.88% to -$8.9 million in 2025.
  • Per Business Quant, the three most recent readings for TBI's Change in Receivables are -$8.9 million (Q4 2025), $26.7 million (Q3 2025), and $6.9 million (Q2 2025).